Cardiovascular Systems
(NSDQ:CSII) today said it has launched its OrbusNeich Jade percutaneous transluminal angioplasty over-the-wire balloon catheter in the U.S.
Jade is an over-the-wire (OTW) balloon catheter for the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae and post-dilation of balloon-expandable and self-expanding stents.
The non-compliant balloon is designed for high-pressure tolerance and balloon dilation with even pressure distribution to treat complex lesions. The balloons are compatible with standard 0.014 in., 0.018 in. and 0.035 in. guidewires and catheters in lengths of 135 cm to 200 cm and balloon working lengths from 20 mm to 240 mm.
“We are excited to announce the full commercial launch of the Jade balloons – an important addition to our peripheral product offering. We believe we will drive meaningful incremental revenue in our peripheral atherectomy cases by offering a comprehensive portfolio of differentiated products designed to save limbs and improve outcomes for patients undergoing complex peripheral interventions,” president and CEO Scott Ward said in a news release.
“The launch of the Jade over-the-wire balloons in the U.S. is a significant milestone for OrbusNeich that will allow us to strengthen our presence in the U.S. alongside our existing percutaneous transluminal coronary angioplasty and PTA portfolio. We are confident that the OTW system will address many physicians’ needs and benefit patients,” OrbusNeich president and CEO David Chien said.
